We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Biosimilars Development Drives Generic-Drug Makers’ Partnerships
Biosimilars Development Drives Generic-Drug Makers’ Partnerships
January 4, 2012
Brand- and generic-drug makers continue to buddy up on biosimilars development with Baxter and Momenta Pharmaceuticals and Watson Pharmaceuticals and Amgen inking collaboration agreements.